CDK Announces Partnership With WE Auto Group

AUSTIN, Texas--(BUSINESS WIRE)-- CDK, the leading automotive retail software provider, today announced a multi-year partnership with WE Auto Group, serving customers in Michigan and Tennessee. WE Auto will implement the CDK Dealership Xperience platform across all four of their dealerships, incorporating the Fixed Operations Suite and Intelligence Suite at certain locations.
"CDK Dealership Xperience delivers a powerful unified workflow platform, comprehensive service and parts solutions, and advanced artificial intelligence capabilities for real-time data insights." - Michael Speigl, WE Auto dealer principal
Share
'After using other software solutions in our dealerships, we realized that the CDK Dealership Xperience platform delivers precisely what we were searching for—a powerful unified workflow platform, comprehensive service and parts solutions, and advanced artificial intelligence capabilities for real-time data insights. These tools are exactly what we need to elevate our sales and service operations to the next level,' said Michael Speigl, dealer principal at WE Auto.
Since the successful launch of the Dealership Xperience in fall 2023, more than 3,000 dealer sites have adopted the new category of software. For more information on the Dealership Xperience and the Suite solutions, please visit https://www.cdkglobal.com/dealership-xperience-platform.
WE Auto offers new and pre-owned vehicles from Chrysler, Dodge, Ford, Jeep, Ram, Subaru and Toyota in Gallatin, Tenn. and Ann Arbor, Mich.
About CDK Global, Inc.
CDK Global is a leading provider of cloud-based software to dealerships and Original Equipment Manufacturers ('OEMs') across automotive and related industries. The Company's cloud-based, software as a service ('SaaS') platform enables dealerships to manage their end-to-end business operations including the acquisition, sale, financing, insuring, repair, and maintenance of vehicles. By automating and streamlining critical workflows, the integrated platform of modern solutions enables dealers to sell and service more vehicles by creating simple and convenient experiences for customers and improves their financial and operational performance.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Wire

11 hours ago

• Business Wire

GE HealthCare drives innovation in theranostics with latest technological advances

CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare's MIM Software introduces LesionID Pro with automated zero-click pre-processing i – an AI-powered innovation to help aid physician decision making and therapy response monitoring. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief Share With cancer accounting for over 10 million deaths globally each year, ii the rise of precision care – particularly theranostics – is offering new hope to patients. By combining advanced diagnostic imaging and radiopharmaceuticals with targeted therapies, theranostics enables a personalized, patient-centric approach that may help improve disease detection, treatment accuracy, and overall quality of life. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief of Nuclear Medicine, Associate Clinical Professor, Department of Radiological Sciences, University of California, Irvine. 'With tools like GE HealthCare's Omni Legend, StarGuide, and MIM software at our disposal, we now have the ability to visualize disease with great clarity, quantify tumor burden efficiently, and make fast, informed decisions. These advancements are not only helping enhance diagnostic accuracy and therapy monitoring but are also opening the door to dosimetry—ultimately helping improve outcomes for our patients. This is precision care in action, and it's making a real difference in patients' lives.' Central to the practice of theranostics is molecular imaging, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), which provides detailed, patient-specific insights to guide and monitor treatment. However, accessing these insights – like whole-body tumor burden, which represents the total amount of cancer is in the body – has traditionally required time-consuming manual analysis, resulting in clinical and operational challenges. In response, GE HealthCare's MIM Software is introducing LesionID Pro with automated zero-click pre-processing, i designed with AI-powered automation to help physicians access reliable whole-body tumor burden statistics without having to spend hours manually segmenting lesions, removing normal physiologic uptake, and registering multiple patient images for comparison. In addition to turning manual pre-processing into a zero-click experience, this new version of LesionID Pro comes with significant algorithm improvements that provide physicians with a precise whole-body tumor volume to review and finalize. Intuitive, user-friendly tools were intentionally designed with input from leading theranostics practitioners with the ultimate goal of making whole-body tumor burden analysis a practical clinical reality and help shorten physicians' time-to-report. 'At GE HealthCare, we are dedicated to providing clinicians the precision care tools needed for the adoption and practice of theranostics,' shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. 'We designed our portfolio of precision care solutions to evolve with healthcare system needs and help support a patient's entire care journey – from the imaging equipment needed for a noninvasive look at a patient's anatomy and treatment monitoring, to novel radiopharmaceuticals used to diagnose and monitor disease and the systems required to produce them, to the software optimized to enable data-driven decision-making. In the hands of clinicians, these tools help advance the global practice of personalized medicine and help improve patient outcomes.' Also on display at #SNMMI25, as part of GE HealthCare's comprehensive portfolio of theranostics-enabling solutions for clinical and operational excellence, are the following innovations: MINItrace Magni, iii GE HealthCare's newest cyclotron technology, designed with a small footprint (about the size of a commercial refrigerator) and the goal of providing an easy-to-site, easy-to-install solution for the reliable, in-house production of commercial PET tracers and radiometals, including Gallium-68, used in diagnostic imaging to support personalized care plans. Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities. Omni Legend is a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands by enabling clinicians to reduce dose by up to 40% iv while maintaining exceptional image quality. Supportive of the diagnostic portion of theranostics, the system continues to gain in popularity, representing the company's fastest-ever-selling PET/CT. v StarGuide is a digital SPECT/CT with a 12 CZT detector design that delivers high-quality 3D images and short scan times. Optimized for certain theranostic procedures, the system is designed to help clinicians pinpoint the size, shape, and position of lesions and monitor therapy with exceptional precision. Its flexibility in patient scanning and workflow efficiencies also support high patient throughput and help reduce complexity. For oncology patients, especially those in pain, short scans can help enhance comfort and overall experience. Aurora is an advanced dual-head SPECT/CT designed with excellent diagnostic capabilities vi and streamline workflows, offering clinicians excellent image quality and operational efficiency. Its CT has a 40 mm detector – twice the detector coverage compared to CTs of other hybrid systems vii – with the ability to reduce the dose up to 82%, viii support accurate quantitation, and help clinicians make the personalized care decisions that are at the heart of theranostics. Theranostics Pathway Manager Tile is an easy-to-use application, available on GE HealthCare's Command Center software, that is designed to simplify the time-consuming task of coordinating the theranostics care pathway. It does so by tracking patient readiness for therapy, eliminating the need for manual data gathering across disparate systems (e.g., labs, scheduling, ordering, spreadsheets), and providing a unified, up-to-date view of each patient's treatment journey. Oregon Health & Science University will be an early adopter. 'Every day counts when it comes to cancer care. The latest theranostics solutions will help our care teams more quickly and easily keep tabs on patient readiness and reduce patient coordination time—freeing up more time for clinicians to focus on direct patient care,' says Erik Mittra, M.D., Ph.D., professor of diagnostic radiology in the at Oregon Health & Science University. Altogether, GE HealthCare has the unique ability to provide solutions along every step of the theranostics care pathway. Our integrated portfolio of solutions provides clinicians with the isotopes, imaging, informatics, and molecular imaging agents necessary for the practice and advancement of precision care. For more information on GE HealthCare's innovative portfolio of theranostics-enabling solutions, please visit SNMMI show attendees are also encouraged stop by the company's booth (#638 and #1023) at New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana from June 21-24. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. i LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region. ii Cancer. World Health Organization. Published February 3, 2022. Accessed March 2, 2023. iii Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not CE marked. iv Omni Legend 21cm as compared to Discovery MI Gen1 20cm. As demonstrated in phantom testing. v Based on orders data of GE HealthCare PET/CT systems since 2010. vi Compared to NM/CT 870 DR. vii As compared to NM/CT 870 DR with Optima 540 CT. viii a ASiR-V reduces dose by 50% to 82% relative to FBP at the same image quality (Image quality as defined by low contrast detectability). viii b In clinical practice, the use of ASiR‐V may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low Contrast Detectability (LCD), Image Noise, Spatial Resolution and Artifact were assessed using reference factory protocols comparing ASiR‐V and FBP. The LCD was measured using 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using a model observer method.

Entrepreneur

20 hours ago

• Entrepreneur

Companies Step Up Reskilling in the Era of AI

AI is not just reshaping industries; it's redefining the future of work. So, it's critical for companies to reskill and upskill their talent to remain relevant and co-exist with AI You're reading Entrepreneur India, an international franchise of Entrepreneur Media. As artificial intelligence (AI) continues to transform industries, companies face a critical challenge: How to prepare their workforce for a future that looks vastly different from the past. To stay relevant, companies are taking on various measures to reskill and upskill their employees to mitigate the risk of turning them redundant. The World Economic Forum estimates that automation will displace 85 million jobs by 2025, and 40 per cent of core skills will change for workers. AI will usher in a new era of productivity and value, and business leaders in the C-suite should make employees part of that future. At IT services company Persistent Systems, continuous learning and development of its people has always been a strategic priority to ensure they remain relevant and future-ready. "Our talent strategy is rooted in a robust learning ecosystem, led by Persistent University and our Digital Engineering Academy. Our Digital Engineering Academy offers AI-personalized learning paths mapped to over 6,500 skills, enabling employees to gain both breadth and depth in emerging technologies," says Dhanashree Bhat, Chief Operating Officer, Persistent Systems. "Over 18,000 employees have completed internal foundational training in GenAI, and our teams have earned close to 4,000 external certifications. Beyond this, we are scaling access to deeper specializations in AI, ML, and GenAI through a mix of internal modules and industry-recognized certifications. We have over 22,000 partner certifications across a range of technologies, including AI, which are critical to driving customer transformation," says Bhat. Fidelity Investments' global capability center (GCC) in India has been a key part of the company's global operations for over two decades. With a talent base of over 7,000 associates in India, it plays a pivotal role in driving innovation and delivering business-critical solutions. "At Fidelity Investments India, we recognise that in today's fast-changing landscape, embracing the cutting edge of technology is key to making a difference. We look to develop solutions and experiences to meet the dynamic business requirements," says Srinivas Gururaja Rau, Head of Fidelity Fund and Investment Operations Technology India, Fidelity Investments. "We have embedded this culture of constant upskilling and reskilling across all levels of the organization. Whether it's through structured programs like LEAP, an upskilling cohort for early-career technologists, role-based learning journeys, internal technology communities, niche hackathon events, our innovation and patent programs, or regular hands-on certification and training programs, we provide a host of opportunities for our technologists to learn and work on the latest emerging technologies in financial services, to innovate for the future," says Rau. ACQUISITIONS AND PARTNERSHIPS Several companies are also acquiring niche startups and leveraging partnerships to enable their reskilling initiatives. For instance, IT major Accenture recently acquired edtech firm TalentSprint from NSE Academy Ltd. The acquisition is expected to bolster Accenture LearnVantage's ability to drive growth through key university certifications and high impact bootcamps, creating trained talent pools for enterprises and governments. As part of the acquisition, TalentSprint's team of approximately 210 professionals will join Accenture LearnVantage. "TalentSprint's end-to-end delivery capabilities of focused learning programs provide a competitive value proposition for learners and enterprises alike, making it a great fit for our expanding LearnVantage business," said Kishore Durg, global lead of Accenture LearnVantage. "The addition of TalentSprint further boosts our ability to meet our clients' demand for training, helping their people gain the essential technology skills in emerging areas needed to reinvent their organizations and achieve greater business value." Saurabh Kumar Sahu, who leads Accenture's India business, added, "India is witnessing a growing need for specialized technology skills at scale as enterprises accelerate their digital transformation efforts and Global Capability Centers evolve into R&D, innovation, and engineering hubs. We see significant opportunities to partner with these organisations to build a pool of readily deployable talent skilled in emerging technologies." The acquisition of TalentSprint complements Accenture's recent investments in Udacity and Award Solutions, and aligns with the company's USD 1 billion investment in LearnVantage over three years, announced in early 2024. "Since inception, our mission has been to equip learners with deep expertise for a disrupted world," said Anurag Bansal, Managing Director and CEO of TalentSprint. "Joining forces with Accenture LearnVantage allows us to scale our impact, delivering cutting-edge technology and next-gen management programs that are valued and trusted by students, professionals, organizations, and governments alike." French IT major Capgemini recently collaborated with the Nasscom Foundation to skill and certify more than 700 disadvantaged youths through their AI for Skilling program. As India moves swiftly towards an AI-driven future, the demand for a workforce proficient in AI competencies continues to grow. Capgemini and the Nasscom Foundation partnership plays a key role in helping to meet this demand by equipping the youth with advanced skills in generative AI, robotics, fintech, and more. Implemented currently in Delhi NCR and Bengaluru, the program is designed to provide a comprehensive 200-hour training, comprising over 140 hours of technical training and more than 60 hours of soft skills development. The initiative builds on Capgemini Digital Academy program, which trains thousands of youths across India in high-demand digital skills, creating opportunities for careers in technology. "AI is shaping a bold new era of work—one where innovation, inclusion, and human potential thrive together. Through Capgemini's Digital Academy, in partnership with Nasscom Foundation, we are bridging the digital divide - equipping the youth with industry-relevant AI and technology skills for meaningful careers. This initiative is also fuelled by the passion of our employee volunteers, who mentor and guide learners, reinforcing our commitment to inclusive growth," says Ashwin Yardi, CEO, Capgemini India. Commenting on the success of the initiative, Jyoti Sharma, CEO, Nasscom Foundation said, "AI is not just reshaping industries, it's redefining the future of work. Our collaboration with Capgemini, under the AI for Skilling initiative, reflects our shared vision of an inclusive digital economy, where marginalized youth have the opportunity to participate and break barriers to AI access. By enabling future-ready skills and focusing on foundational, core-work skills, we are investing in the potential of India's youth to fully embrace evolving digital opportunities." To ensure holistic development, the initiative extended beyond technical training and included expert sessions conducted by industry professionals, as well as aptitude-building modules, and awareness programs. Real-world exposure was also facilitated through corporate volunteer engagement and industry visits, helping learners gain insights into workplace expectations and the professional culture of the technology sector. CO-EXISTENCE OF HUMANS AND AI Persistent Systems is of the view that collaboration between human expertise and AI is a "force multiplier". As GenAI becomes integral to business workflows, it's driving faster decisions, greater scale, and more dynamic operations. In fact, according to McKinsey, 71 per cent of business leaders now report using GenAI in at least one function, up from 65 per cent in early 2024. "We follow a human-in-the-loop approach, where employees are involved in training models, prompt engineering, and validating outputs, ensuring AI remains contextually relevant, ethical, unbiased, and aligned with business goals. Our focus is on outcome-based learning. From customer interview coaching to internal mobility programs, we help employees apply AI-first thinking to solve real problems, bridging skill development with delivery impact," says Bhat. He says that across industries, roles are being redefined. Developers are moving beyond manual coding toward solution design, while business teams are using AI to personalize experiences and accelerate decisions. This shift empowers talent to focus on higher-value, creative, and strategic work. Ultimately, AI is elevating human potential, and that synergy is shaping more agile, future-ready workforces capable of delivering stronger outcomes in a dynamic, technology-first world.

Business Wire

a day ago

• Business Wire

EMEREN GROUP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Emeren Group Ltd.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Emeren Group Ltd. (NYSE: SOL) to Shurya Vitra Ltd. Under the terms of the proposed transaction, shareholders of Emeren Group will receive $0.20 in cash per ordinary share or $2.00 in cash per American Depositary Share. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit